CSIMarket
 


Pulmonx Corporation  (LUNG)
Other Ticker:  
 
 

LUNG's Revenue Growth by Quarter and Year

Pulmonx's Revenue results by quarter and year




LUNG Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 19.45 15.43 13.71
III Quarter September - 17.03 13.50 13.26
II Quarter June - 16.73 13.95 12.20
I Quarter March 18.08 14.54 10.79 9.24
FY   18.08 67.75 53.67 48.41



LUNG Revenue first quarter 2024 Y/Y Growth Comment
Pulmonx Corporation reported Revenue improvement of 24.33% year on year in the first quarter 2024, to $ 18.08 millions, this is lower than Pulmonx Corporation's recent average Revenue rise of 46.49%.

Looking into first quarter 2024 results within Medical Equipment & Supplies industry 62 other companies have achieved higher Revenue growth. While Pulmonx Corporation' s Revenue rise of 24.33% ranks overall at the positon no. 991 in the first quarter 2024.




LUNG Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 26.05 % 12.55 % -
III Quarter September - 26.15 % 1.81 % 24.98 %
II Quarter June - 19.93 % 14.34 % -
I Quarter March 24.33 % 34.75 % 16.77 % -
FY   - 26.23 % 10.87 % -

Financial Statements
Pulmonx's first quarter 2024 Revenue $ 18.08 millions LUNG's Income Statement
Pulmonx's first quarter 2023 Revenue $ 14.54 millions Quarterly LUNG's Income Statement
New: More LUNG's historic Revenue Growth >>


LUNG Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 14.21 % 14.3 % 3.39 %
III Quarter September - 1.79 % -3.23 % 8.69 %
II Quarter June - 15.06 % 29.29 % 32.03 %
I Quarter March -7.05 % -5.77 % -21.3 % -
FY (Year on Year)   - 26.23 % 10.87 % -




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #63
Healthcare Sector #188
Overall #991

Revenue Y/Y Growth Statistics
High Average Low
141.08 % 46.49 % 10.84 %
(Jun 30 2022)   (Dec 31 2022)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #63
Healthcare Sector #188
Overall #991
Revenue Y/Y Growth Statistics
High Average Low
141.08 % 46.49 % 10.84 %
(Jun 30 2022)   (Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Pulmonx's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
32.01 % 6.78 % -21.32 %
(Jun 30 2021)  


LUNG's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Pulmonx Corporation reported drop in Revenue sequentially by -7.05% to $ 18.08 millions, from $ 19.45 millions declared a quarter before.

As we analyse current slump in the I. Quarter 2024, we suppose to take into consideration, that usually I. Quarter 2024 results occur weaker in contrast to the quarter before

Within Medical Equipment & Supplies industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Pulmonx's Revenue growth quarter on quarter, overall rank is 1779.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #79
Healthcare Sector #221
Overall #1779
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #79
Healthcare Sector #221
Overall #1779
Revenue Q/Q Growth Statistics
High Average Low
32.01 % 6.78 % -21.32 %
(Jun 30 2021)  


LUNG's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Pulmonx Corporation realized drop in Revenue from the previous quarter by -7.05% to $ 18.08 millions, from $ 19.45 millions declared in the previous reporting period.

This is not huge issue, as Revenue always gravitate to plunge in the I. Quarter Andrew Evans, a business contributor based in Chicago wrote.

Within Medical Equipment & Supplies industry 78 other companies have achieved higher Revenue quarter on quarter growth. While Pulmonx's Revenue growth quarter on quarter, overall rank is 1779.


Pulmonx's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 71.30 $ 67.75 $ 63.72 $ 60.20 $ 57.41
Y / Y Revenue Growth (TTM) 24.18 % 26.26 % 22.67 % 16.42 % 14.92 %
Year on Year Revenue Growth Overall Ranking # 603 # 592 # 36 # 58 # 55
Seqeuential Revenue Change (TTM) 5.23 % 6.32 % 5.86 % 4.85 % 6.99 %
Seq. Revenue Growth (TTM) Overall Ranking # 991 # 1004 # 2045 # 1148 # 1231




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2024 period, Pulmonx's cumulative twelve months Revenue were $ 71 millions, company would post below average annual Revenue growth of 6.99% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Pulmonx's Revenue growth from the 19.45% growth in Dec 31 2023.

In the Healthcare sector 134 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 592 to 603.

Revenue TTM Q/Q Growth Statistics
High Average Low
141.08 %
46.49 %
10.84 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 63
Healthcare Sector # 135
Overall # 603

Revenue TTM Y/Y Growth Statistics
High Average Low
141.08 %
46.49 %
10.84 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 63
Sector # 188
S&P 500 # 991
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2024 period, Pulmonx's cumulative twelve months Revenue were $ 71 millions, company would post below average annual Revenue growth of 10.84% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Pulmonx's Revenue growth from the 19.45% growth in Dec 31 2023.

In the Healthcare sector 134 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 592 to 603.

Revenue TTM Q/Q Growth Statistics
High Average Low
141.08 %
46.49 %
10.84 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 63
Healthcare Sector # 135
Overall # 603

Revenue TTM Y/Y Growth Statistics
High Average Low
141.08 %
46.49 %
10.84 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 63
Sector # 188
S&P 500 # 991




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LUNG's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LUNG's Competitors
Revenue Growth for Pulmonx's Suppliers
Revenue Growth for LUNG's Customers

You may also want to know
LUNG's Annual Growth Rates LUNG's Profitability Ratios LUNG's Asset Turnover Ratio LUNG's Dividend Growth
LUNG's Roe LUNG's Valuation Ratios LUNG's Financial Strength Ratios LUNG's Dividend Payout Ratio
LUNG's Roa LUNG's Inventory Turnover Ratio LUNG's Growth Rates LUNG's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Adma Biologics Inc 42.51%$ 42.511 millions
Evolus Inc 42.21%$ 42.214 millions
Agilon Health Inc 41.21%$ 41.210 millions
Clearpoint Neuro Inc 40.60%$ 40.604 millions
Orthopediatrics Corp39.84%$ 39.844 millions
Theravance Biopharma inc 39.22%$ 39.224 millions
Corcept Therapeutics Inc38.95%$ 38.952 millions
Zai Lab Limited38.78%$ 38.779 millions
Qhslab Inc 38.49%$ 38.489 millions
Tela Bio Inc 38.28%$ 38.277 millions
Shockwave Medical Inc 35.72%$ 35.720 millions
Biocryst Pharmaceuticals Inc 34.87%$ 34.870 millions
Deciphera Pharmaceuticals Inc 34.55%$ 34.546 millions
United Therapeutics Corporation33.70%$ 33.695 millions
Cyclo Therapeutics Inc 32.83%$ 32.832 millions
Lifemd Inc 32.31%$ 32.307 millions
Maxcyte inc 32.25%$ 32.248 millions
Eton Pharmaceuticals Inc 32.11%$ 32.108 millions
Agile Therapeutics Inc32.07%$ 32.074 millions
Guardant Health Inc 30.90%$ 30.903 millions
Harrow Inc 30.38%$ 30.383 millions
Harmony Biosciences Holdings inc 29.38%$ 29.385 millions
Axonics Inc 29.16%$ 29.162 millions
Ani Pharmaceuticals Inc28.70%$ 28.697 millions
P3 Health Partners Inc 28.61%$ 28.606 millions
Exagen Inc 28.36%$ 28.362 millions
Viemed Healthcare Inc 27.90%$ 27.902 millions
Inspire Medical Systems inc 27.64%$ 27.644 millions
Sintx Technologies Inc 27.46%$ 27.458 millions
Amicus Therapeutics inc 27.32%$ 27.317 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com